CLINICAL CHARACTERISTICS, TREATMENT PATTERNS, AND HEALTH CARE RESOURCE UTILIZATION IN UNRESECTABLE, LOCALLY ADVANCED, STAGE III NON-SMALL CELL LUNG CANCER: A MEDICAL RECORD REVIEW STUDY IN THE UNITED STATES AND CANADA

被引：1
|
作者：
Kurosky, S. [1 ]
Klein, A. B. [2 ]
Parikh, R. C. [1 ]
Trantham, L. [1 ]
Zhang, Y. [2 ]
Levine, C. A. [1 ]
Kaye, J. A. [3 ]
机构：
[1] RTI Hlth Solut, Res Triangle Pk, NC USA
[2] AstraZeneca, Gaithersburg, MD USA
[3] RTI Hlth Solut, Waltham, MA USA
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
10.1016/j.jval.2018.04.286
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN239
引用
收藏
页码：S49 / S49
页数：1
相关论文
共 50 条
  • [21] Treatment sequencing for the care of patients with advanced or metastatic non-small cell lung cancer in the United States
    Hess, Lisa M.
    Cui, Zhanglin Lin
    Li, Xiaohong Ivy
    Molife, Cliff
    Oton, Ana B.
    CURRENT MEDICAL RESEARCH AND OPINION, 2021, 37 (03) : 469 - 476
  • [22] A narrative review of toxicity of chemoradiation and immunotherapy for unresectable, locally advanced non-small cell lung cancer
    Prasad, Rahul N.
    Williams, Terence M.
    TRANSLATIONAL LUNG CANCER RESEARCH, 2020, 9 (05) : 2040 - 2050
  • [23] Real-world treatment patterns, clinical outcomes, and health care resource utilization in extensive-stage small cell lung cancer in Canada.
    O'Sullivan, Dylan E.
    Brenner, Darren
    Syed, Iqra
    Shanahan, Mary Kate
    Moldaver, Daniel
    Sit, Christina
    Bebb, D. Gwyn
    Cheung, Winson Y.
    Boyne, Devon J.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [24] Treatment Patterns and Health Care Resource Utilization of Patients With Non-Small Cell Lung Cancer in Puerto Rico: The TREATLINES-ONCOLUNG Study
    Miranda, Edgar I.
    Gierbolini-Bermudez, Axel
    Quintana, Rafael
    Torres-Cintron, Carlos R.
    Ortiz-Ortiz, Karen J.
    JCO GLOBAL ONCOLOGY, 2024, 10
  • [25] The treatment in patients with unresectable locally advanced non-small cell lung cancer: Explorations on hot issues
    Wang, Yimeng
    Wang, Yao
    Yu, Jinming
    Meng, Xiangjiao
    CANCER LETTERS, 2022, 551
  • [26] A new standard of care for patients with surgically unresectable stage III non-small cell lung cancer
    Gill, Harpaul S.
    Ramalingam, Suresh S.
    CANCER, 2019, 125 (13) : 2148 - 2153
  • [27] Retrospective cohort study of unresectable stage III non-small-cell lung cancer in Canada
    Seung, S. J.
    Hurry, M.
    Walton, R. N.
    Evans, W. K.
    CURRENT ONCOLOGY, 2020, 27 (04) : E354 - E360
  • [28] Utilization and factors precluding the initiation of consolidative durvalumab in unresectable stage III non-small cell lung cancer
    Shaverdian, Narek
    Offin, Michael D.
    Rimner, Andreas
    Shepherd, Annemarie F.
    Wu, Abraham J.
    Rudin, Charles M.
    Hellmann, Matthew D.
    Chaft, Jamie E.
    Gomez, Daniel R.
    RADIOTHERAPY AND ONCOLOGY, 2020, 144 : 101 - 104
  • [29] Perspective on treatment for unresectable locally advanced non-small cell lung cancer with oncogene-driven mutation: a narrative review
    Jiang, Liyang
    Meng, Xiangjiao
    Zhao, Xianguang
    Xing, Ligang
    Yu, Jinming
    TRANSLATIONAL LUNG CANCER RESEARCH, 2020, 9 (05) : 2137 - 2144
  • [30] Locally advanced, stage III non-small cell lung cancer: A highly heterogenous patient population
    Soares, M. A. S.
    Goncalves-Monteiro, S.
    Antunes, L.
    Bernardo, F.
    Figueiredo, S.
    Borges, M.
    Bento, M. J.
    Redondo, P. V.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (04) : S735 - S735
12345